Company intelligence / Profile preview
CellMed
Seoul, South Koreacellmed.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
2,500+ member pharmacies in Korea as of Feb.2024, US market entry with Atlanta pharmacy in July.2023, Patent portfolio covering anti-aging and oncology formulations since.2018
- Therapeutic areas
- OtherNeurologyRheumatology
- Modalities
- Natural compoundsStem cell therapy (via Cellmed Life)Micro-implants (via CellMed Germany)
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
Seoul Pharmacist AssociationGyeongnam Changwon Pharm Expo organizers
Beyond the preview
Go deeper on CellMed.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CellMed.